John Wrangle

Concepts (204)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung
11
2018
300
2.330
Why?
Lung Neoplasms
13
2021
1173
1.820
Why?
Immunotherapy
4
2018
215
1.070
Why?
Interleukin-15
3
2022
66
1.070
Why?
Interleukin-2
3
2018
133
0.870
Why?
CD8-Positive T-Lymphocytes
2
2022
266
0.820
Why?
Antineoplastic Agents, Immunological
4
2021
66
0.820
Why?
Circulating MicroRNA
1
2020
9
0.740
Why?
Extracellular Vesicles
1
2020
21
0.730
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2021
468
0.700
Why?
Azacitidine
4
2020
20
0.650
Why?
Programmed Cell Death 1 Receptor
5
2022
87
0.640
Why?
Adoptive Transfer
2
2018
100
0.610
Why?
DNA Methylation
7
2021
193
0.570
Why?
MicroRNAs
1
2020
447
0.520
Why?
Positron-Emission Tomography
1
2016
160
0.510
Why?
B7-H1 Antigen
4
2020
30
0.490
Why?
Proteins
1
2018
474
0.470
Why?
Cysteine Dioxygenase
1
2014
1
0.470
Why?
Tachykinins
1
2014
8
0.470
Why?
T-Lymphocytes
1
2017
597
0.450
Why?
Antimetabolites, Antineoplastic
1
2013
77
0.450
Why?
Neoplasms
3
2021
1667
0.440
Why?
Homeodomain Proteins
1
2014
157
0.430
Why?
Carcinoma, Squamous Cell
3
2021
629
0.430
Why?
Melanoma
3
2022
335
0.420
Why?
Biomarkers, Tumor
6
2018
508
0.380
Why?
Recombinant Fusion Proteins
2
2022
376
0.320
Why?
Battered Women
1
2008
15
0.310
Why?
Cultural Characteristics
1
2008
42
0.310
Why?
Spouse Abuse
1
2008
40
0.300
Why?
Neoplasm Staging
4
2021
800
0.300
Why?
Melanoma, Experimental
2
2019
95
0.300
Why?
Skin Neoplasms
2
2022
375
0.290
Why?
Humans
27
2022
68618
0.290
Why?
Anticarcinogenic Agents
1
2007
52
0.290
Why?
Head and Neck Neoplasms
2
2015
561
0.280
Why?
Retinoids
1
2007
122
0.270
Why?
DNA
3
2021
597
0.250
Why?
Epigenesis, Genetic
4
2020
163
0.230
Why?
Mouth Neoplasms
2
2021
206
0.230
Why?
Immunotherapy, Adoptive
3
2018
132
0.200
Why?
Genetic Therapy
3
2020
291
0.200
Why?
Mass Screening
1
2008
843
0.200
Why?
Healthy Volunteers
1
2022
78
0.200
Why?
Aged
11
2022
14862
0.200
Why?
Tumor Microenvironment
2
2020
213
0.190
Why?
Immunoconjugates
1
2021
26
0.190
Why?
Cell Line, Tumor
5
2019
1851
0.190
Why?
Early Detection of Cancer
2
2016
454
0.180
Why?
Myeloid-Derived Suppressor Cells
1
2020
21
0.180
Why?
Benzamides
3
2020
156
0.180
Why?
Amino Acid Transport Systems
1
2019
3
0.170
Why?
Middle Aged
11
2021
21147
0.170
Why?
Symporters
1
2019
27
0.170
Why?
Cyclin-Dependent Kinase 6
1
2019
28
0.170
Why?
Cyclin-Dependent Kinase 4
1
2019
36
0.170
Why?
Pyridines
3
2020
261
0.170
Why?
Neoplasm Recurrence, Local
1
2021
446
0.160
Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2018
10
0.160
Why?
HLA-DR Antigens
1
2018
41
0.160
Why?
Signal Transduction
2
2019
2689
0.150
Why?
Female
13
2021
38074
0.150
Why?
Interleukin Receptor Common gamma Subunit
1
2017
7
0.150
Why?
Drug Resistance, Neoplasm
1
2019
332
0.140
Why?
Interleukin-7
1
2017
18
0.140
Why?
Neoplasm Proteins
1
2019
307
0.140
Why?
Protein Kinase Inhibitors
1
2019
331
0.140
Why?
Precision Medicine
1
2018
111
0.140
Why?
Positron Emission Tomography Computed Tomography
1
2016
38
0.140
Why?
Th17 Cells
1
2017
116
0.130
Why?
Medical Oncology
1
2016
110
0.130
Why?
Kaplan-Meier Estimate
2
2014
536
0.130
Why?
Male
11
2021
37321
0.120
Why?
Treatment Outcome
4
2021
7029
0.120
Why?
United States
4
2022
7367
0.120
Why?
Lymphocytes
1
2015
228
0.120
Why?
Neutrophils
1
2015
204
0.120
Why?
Promoter Regions, Genetic
1
2016
615
0.120
Why?
CpG Islands
1
2014
51
0.120
Why?
HIV Seropositivity
1
2014
66
0.110
Why?
Epigenomics
1
2013
29
0.110
Why?
Disease-Free Survival
4
2017
349
0.110
Why?
Antineoplastic Agents
2
2017
1070
0.110
Why?
Colorectal Neoplasms
1
2018
561
0.100
Why?
Sensitivity and Specificity
3
2016
1753
0.100
Why?
DNA-Cytosine Methylases
1
2012
1
0.100
Why?
Lymphoma, Primary Effusion
1
2012
7
0.100
Why?
Polymerase Chain Reaction
1
2013
492
0.100
Why?
Tumor Suppressor Proteins
1
2013
194
0.100
Why?
Herpesvirus 8, Human
1
2012
24
0.100
Why?
Sarcoma, Kaposi
1
2012
25
0.100
Why?
Proportional Hazards Models
1
2014
792
0.100
Why?
DNA, Viral
1
2012
114
0.100
Why?
Pneumonectomy
1
2012
79
0.100
Why?
Lung
1
2016
849
0.100
Why?
Up-Regulation
1
2013
682
0.090
Why?
Prognosis
4
2018
2093
0.090
Why?
Animals
6
2020
20881
0.090
Why?
Apoptosis
1
2017
1641
0.090
Why?
Time Factors
1
2018
4655
0.090
Why?
Medicare
2
2022
319
0.080
Why?
Combined Modality Therapy
2
2011
951
0.080
Why?
Smoking
2
2014
1452
0.080
Why?
Antibodies, Monoclonal, Humanized
2
2021
151
0.080
Why?
Neoplasm Metastasis
2
2020
306
0.080
Why?
Georgia
1
2008
161
0.070
Why?
Communication Barriers
1
2008
48
0.070
Why?
Chemoprevention
1
2007
26
0.070
Why?
Women's Health
1
2008
148
0.070
Why?
Urban Population
1
2008
255
0.070
Why?
Retrospective Studies
4
2022
7277
0.070
Why?
Cohort Studies
3
2021
2358
0.060
Why?
Mice
4
2020
8474
0.060
Why?
HIV Infections
1
2012
791
0.060
Why?
Clinical Trials as Topic
1
2007
848
0.050
Why?
Histones
2
2015
111
0.050
Why?
CTLA-4 Antigen
1
2022
45
0.050
Why?
Risk Assessment
1
2008
2007
0.050
Why?
Neoadjuvant Therapy
1
2021
104
0.050
Why?
Adult
4
2018
21403
0.050
Why?
Benzodiazepinones
1
2021
4
0.050
Why?
Ipilimumab
1
2021
10
0.050
Why?
Case-Control Studies
2
2016
1553
0.050
Why?
Receptors, CCR2
1
2020
9
0.040
Why?
Receptors, Interleukin-8B
1
2020
9
0.040
Why?
Carcinogenesis
1
2021
124
0.040
Why?
Calmodulin-Binding Proteins
1
1999
6
0.040
Why?
Phosphopeptides
1
1999
8
0.040
Why?
Chemotherapy, Adjuvant
1
2020
129
0.040
Why?
Survival Analysis
1
2021
714
0.040
Why?
Surveys and Questionnaires
1
2008
2800
0.040
Why?
Mechanistic Target of Rapamycin Complex 1
1
2019
32
0.040
Why?
Xenograft Model Antitumor Assays
1
2019
304
0.040
Why?
Retreatment
1
2018
59
0.040
Why?
Down-Regulation
1
2020
447
0.040
Why?
Lymphocyte Depletion
1
2018
34
0.040
Why?
Smoking Cessation
1
2007
1034
0.040
Why?
Microsatellite Instability
1
2018
39
0.040
Why?
Muscle, Smooth, Vascular
1
1999
317
0.040
Why?
Lymphocytes, Tumor-Infiltrating
1
2018
91
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2021
756
0.040
Why?
Cell Movement
1
2020
630
0.040
Why?
T-Lymphocytes, Regulatory
1
2018
199
0.030
Why?
Sputum
1
2016
51
0.030
Why?
Biopsy
1
2018
540
0.030
Why?
Lymphocyte Activation
1
2018
397
0.030
Why?
Area Under Curve
1
2016
238
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2016
209
0.030
Why?
Lymphocyte Count
1
2015
53
0.030
Why?
Mutation
1
2021
1213
0.030
Why?
Cell Differentiation
1
2020
1034
0.030
Why?
Immunohistochemistry
1
2018
1174
0.030
Why?
ROC Curve
1
2016
392
0.030
Why?
CD4-Positive T-Lymphocytes
1
2017
226
0.030
Why?
Protein Binding
1
2018
1027
0.030
Why?
Transcriptome
1
2016
164
0.030
Why?
Camptothecin
1
2015
39
0.030
Why?
Neoplasm Transplantation
1
2015
160
0.030
Why?
Mice, Inbred NOD
1
2015
138
0.030
Why?
Drug Evaluation, Preclinical
1
2015
137
0.030
Why?
Mice, SCID
1
2015
238
0.030
Why?
Gene Expression Profiling
1
2016
498
0.030
Why?
Models, Biological
1
2018
981
0.030
Why?
CD4 Lymphocyte Count
1
2014
98
0.030
Why?
Molecular Targeted Therapy
1
2015
170
0.030
Why?
Sulfites
1
2013
7
0.030
Why?
Microspheres
1
2013
59
0.030
Why?
Pulmonary Emphysema
1
2014
71
0.030
Why?
HeLa Cells
1
2013
237
0.030
Why?
Survival Rate
1
2015
1056
0.030
Why?
Cell Proliferation
1
2017
1174
0.030
Why?
Disease Models, Animal
1
2020
2550
0.030
Why?
Pulmonary Diffusing Capacity
1
2012
12
0.030
Why?
Methylation
1
2012
56
0.030
Why?
Actins
1
2013
249
0.030
Why?
Maryland
1
2012
77
0.030
Why?
Cell Survival
1
2015
901
0.030
Why?
Carbon Monoxide
1
2012
58
0.020
Why?
Mice, Inbred C57BL
1
2018
2791
0.020
Why?
Gene Expression Regulation
1
2017
1293
0.020
Why?
Gene Expression
1
2013
770
0.020
Why?
Randomized Controlled Trials as Topic
1
2015
931
0.020
Why?
Incidence
1
2014
1603
0.020
Why?
Prevalence
1
2014
1619
0.020
Why?
Age Factors
1
2014
1864
0.020
Why?
Socioeconomic Factors
1
2012
955
0.020
Why?
Disease Progression
1
2011
1038
0.020
Why?
Patient Selection
1
2012
592
0.020
Why?
Comorbidity
1
2012
1426
0.020
Why?
Prospective Studies
1
2014
3705
0.020
Why?
Tomography, X-Ray Computed
1
2014
2324
0.010
Why?
Risk Factors
1
2014
5731
0.010
Why?
Postoperative Complications
1
2012
1615
0.010
Why?
Aged, 80 and over
1
2011
4848
0.010
Why?
Sequence Homology, Amino Acid
1
1999
231
0.010
Why?
Mitogen-Activated Protein Kinase 3
1
1999
147
0.010
Why?
Antibodies
1
1999
241
0.010
Why?
Mitogen-Activated Protein Kinases
1
1999
250
0.010
Why?
In Vitro Techniques
1
1999
765
0.010
Why?
Swine
1
1999
672
0.010
Why?
Amino Acid Sequence
1
1999
1083
0.010
Why?
Molecular Sequence Data
1
1999
1447
0.010
Why?
Phosphorylation
1
1999
1200
0.010
Why?
Wrangle's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (204)
Explore
_
Co-Authors (44)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_